Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JBM (Healthcare)'s dividends per share for the
six
months ended in Mar. 2026 was HK$0.10. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was HK$0.21. Its Dividend Payout Ratio for the
six
months ended in Mar. 2026 was 0.93. As of today, JBM (Healthcare)'s Dividend Yield % is 11.16%.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JBM (Healthcare) Ltd is 0.86, which seems too high.
Good Sign:
JBM (Healthcare) Ltd stock Dividend Yield % is close to 5-year high.
During the past 12 months, JBM (Healthcare)'s average Dividends Per Share Growth Rate was 121.90% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 249.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 9 years, the highest 3-Year average Dividends Per Share Growth Rate of JBM (Healthcare) was 249.30% per year. The lowest was 249.30% per year. And the median was 249.30% per year.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
During the past 9 years, the highest Dividend Payout Ratio of JBM (Healthcare) was 0.86. The lowest was 0.09. And the median was 0.41.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of JBM (Healthcare) Ltd is 0.86, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
JBM (Healthcare) Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
HKD 0.097500
2025-11-28
2025-12-02
2025-12-17
Cash Dividend
semi-annually
HKD:HKD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
JBM (Healthcare)'s Dividend Yield (%) for Today is calculated as
Current Share Price is HK$1.905.
JBM (Healthcare)'s Dividends per Share for the trailing twelve months (TTM) ended in Today is HK$0.0975.
During the past 9 years, the highest Dividend Yield of JBM (Healthcare) was 11.39%. The lowest was 0.38%. And the median was 3.35%.
Good Sign:
JBM (Healthcare) Ltd stock Dividend Yield % is close to 5-year high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JBM (Healthcare) Dividends per Share Related Terms
JBM (Healthcare) Dividends per Share Historical Data
* Premium members only.
The historical data trend for JBM (Healthcare)'s Dividends per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, JBM (Healthcare)'s Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JBM (Healthcare) Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, JBM (Healthcare)'s Dividend Yield % distribution charts can be found below:
* The bar in red indicates where JBM (Healthcare)'s Dividend Yield % falls into.
JBM (Healthcare) (HKSE:02161) has a Dividends per Share of HK$0.21 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on JBM (Healthcare) and its competitors.
Is JBM (Healthcare)'s Dividends per Share too high?
JBM (Healthcare)'s current Dividends per Share is HK$0.21. Overall, JBM (Healthcare) has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JBM (Healthcare)'s Dividends per Share compare to ZTS?
JBM (Healthcare)'s Dividends per Share of HK$0.21 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividends per Share for a Drug Manufacturers company?
A good Dividends per Share depends on the Drug Manufacturers industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividends per Share mean?
A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on JBM (Healthcare) and its competitors. JBM (Healthcare)'s current Dividends per Share is HK$0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JBM (Healthcare) stock overvalued right now?
Based on GuruFocus' analysis, JBM (Healthcare) (HKSE:02161) is currently considered Fairly Valued. The stock's GF Value™ is HK$2.09, compared to a current price of HK$1.91 — trading 8.9% below its estimated fair value. The current Dividends per Share is HK$0.21. JBM (Healthcare)'s overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividends per Share calculated?
Dividends per Share is calculated from a company's financial statements. For JBM (Healthcare) (HKSE:02161), the current Dividends per Share is HK$0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JBM (Healthcare) (HKSE:02161) Overvalued in 2026?
Based on GuruFocus' analysis, JBM (Healthcare) stock appears to be undervalued.
The current stock price of HK$1.91 is trading 8.9% below its estimated GF Value™ of HK$2.09.
GuruFocus considers JBM (Healthcare) to be Fairly Valued.
Key valuation signals for HKSE:02161:
Dividends per Share: HK$0.21
GF Value™: HK$2.09 vs. price of HK$1.91 (8.9% below fair value)
No single metric tells the full story. See the HKSE:02161 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
86GF Score
Get the complete analysis for HKSE:02161
Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02161 has been successfully added to your 
